2012
DOI: 10.1017/s0022215112002356
|View full text |Cite
|
Sign up to set email alerts
|

Skull base osteomyelitis: current microbiology and management

Abstract: Our treatment algorithm reflects the need for multidisciplinary input, early microbial culture of specimens, appropriate imaging, and prolonged and systemic antimicrobial treatment. Resolution of infection must be confirmed by close follow up and imaging.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
28
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(30 citation statements)
references
References 25 publications
1
28
1
Order By: Relevance
“…Ciprofloxacin has since been widely used in the treatment of osteomyelitis of the temporal bone. 25,26 Antibiotic therapy can last several months. However, there have been recent reports of resistance of Pseudomonas to ciprofloxacin therapy in temporal bone osteomyelitis.…”
Section: Treatmentmentioning
confidence: 99%
“…Ciprofloxacin has since been widely used in the treatment of osteomyelitis of the temporal bone. 25,26 Antibiotic therapy can last several months. However, there have been recent reports of resistance of Pseudomonas to ciprofloxacin therapy in temporal bone osteomyelitis.…”
Section: Treatmentmentioning
confidence: 99%
“…Pseudomonas aeruginosa is the commonly isolated organism, representing more than 50% in most of the series, followed by methicillin-resistant Staphylococcus aureus and Klebsiella pneumonia ( Chen et al., 2010 ; Ali et al., 2010 ; Loh and Loh, 2013 ; Stern Shavit et al., 2016 ; Lee et al, 2008, 2017; Hobson et al., 2014 ; Le Clerc et al., 2014 ). Though the causative organism was identified to be Pseudomonas in our case, the culture reports may not always yield positive results ( Ali et al., 2010 ; Loh and Loh, 2013 ; Lee et al, 2008, 2017; Spielmann et al., 2013 ; Le Clerc et al., 2014 ; Sokołowski et al., 2019 ). Irrespective of the culture reports, the empirical treatment with ceftazidime and fluoroquinolone combination has been shown to be equally efficacious as culture-directed antibiotic therapy in MOE ( Loh and Loh, 2013 ; Sokołowski et al., 2019 ).…”
Section: Discussionmentioning
confidence: 56%
“…Malignant otitis externa (MOE) also known as otogenic skull base osteomyelitis (SBO) is an inflammatory condition of the external ear and adjacent temporal bone that is commonly seen in diabetic patients, and is attributed to Pseudomonas infection ( Karaman et al., 2012 ; Blyth et al., 2011 ; Chen et al., 2010 ; Carfrae and Kesser, 2008 ; Ali et al., 2010 ; Das et al., 2019 ; Loh and Loh, 2013 ; Stern Shavit et al., 2016 ; Lee et al., 2008 ; Spielmann et al., 2013 ). Despite aggressive antibiotic therapy, many of the affected patients have an extension of the disease to surrounding soft tissue and bones of the skull base ( Chen et al., 2010 ; Carfrae and Kesser, 2008 ).…”
Section: Introductionmentioning
confidence: 99%
“…In the differential diagnosis for skull base osteomyelitis, MRI or CT should be used to rule out other conditions, especially malignancy (9). In the cranial MR signal changes in the skull base bone marrow take place as the loss of cortical definition and contrastholding appearance in the affected regions.…”
Section: Discussionmentioning
confidence: 99%